Intrinsic Value

VYYRF doesn't have a meaningful market cap.

The intrinsic value of Voyageur Pharmaceuticals Ltd (VYYRF) under the Base Case is USD per share. Compared with the current market price of 0.089 USD, the stock appears .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

VYYRF Intrinsic Value

What one share is worth in the bear, base and bull cases.

Create a free account · No card needed

Do our valuations actually work? See backtest results .

Alert me when VYYRF is below its intrinsic value
Today Hidden ·
VYYRF Valuation History

Intrinsic value next to the price over the past 5 years.

Create a free account · No card needed

Alternatives to VYYRF

Fundamental Analysis

What Voyageur Pharmaceuticals Does

Voyageur Pharmaceuticals Ltd is a Canadian specialty pharmaceutical company focused on diagnostic imaging products. It works on contrast agents, especially barium-based products used to help doctors see the gastrointestinal tract in X-ray and CT imaging. The company also develops related formulations and mineral-based pharmaceutical ingredients that sit upstream in the medical imaging supply chain.

Headquarters
Canada CA
IPO date
May 18, 2012
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue VYYRF Research

Decided on Voyageur Pharmaceuticals? Get an email when VYYRF reaches the price you’d buy at. Free with an account.

Other Voyageur Pharmaceuticals listings

What is the Intrinsic Value of one VYYRF stock?

The intrinsic value for Voyageur Pharmaceuticals Ltd (VYYRF) under the Base Case is USD.

Is VYYRF stock undervalued or overvalued?

Compared with the current market price of 0.089 USD, the stock appears .

How reliable are our estimates? See how past valuations played out
Back to Top